People

Steven K. Libutti, MD, was appointed director of Rutgers Cancer Institute of New Jersey in New Brunswick, effective January 10. He will also serve as vice chancellor for cancer programs for Rutgers Biomedical and Health Sciences at Rutgers University. He replaces Bruce G. Haffty, MD, who had been serving as interim director. Previously, Libutti served as director for the Montefiore Einstein Center for Cancer Care in New York, NY. A surgical oncologist, he is an internationally known expert in endocrine surgery and the management of neuroendocrine tumors.

David A. Tuveson, MD, PhD, became director of the Cold Spring Harbor Laboratory Cancer Center in New York, where he had been directing the Cancer Therapeutics Initiative, in late November. He succeeds Bruce W. Stillman, PhD, who served as the center's director for 25 years. Tuveson's research focuses on finding methods to detect pancreatic cancer earlier in the disease course and designing novel therapeutic approaches, based in part on pancreatic organoid technology, which he has pioneered. He also serves as the director of research for the Lustgarten Foundation, which funds pancreatic cancer research.

Stanton L. Gerson, MD, began a 2-year term as president of the Association of American Cancer Institutes, which represents 96 academic and freestanding cancer research centers in the United States and Canada, at the organization's annual meeting last fall. Gerson serves as the director of the NCI-designated Case Comprehensive Cancer Center and the University Hospital Seidman Cancer Center, both in Cleveland, OH. A highly regarded investigator, he has been involved in research programs related to stem cells, hematologic malignancies, and developmental therapeutics.

For more news on cancer research, visit Cancer Discovery online at http://cancerdiscovery.aacrjournals.org/content/early/by/section.